Patents Assigned to NUDGE BG, INC.
  • Patent number: 12283361
    Abstract: Some embodiments include burden-free insulin delivery systems and methods. Some embodiments include a method comprising: receiving previous insulin delivery data at a user device from an insulin pump; receiving estimated glucose data at the user device from a continuous glucose monitor; determining that the estimated glucose value is approaching or has passed a threshold; and in response to determining that the estimated glucose value is approaching or has surpassed the threshold, not providing an indication to the user through a user interface that the estimated glucose value is approaching or surpassed the threshold.
    Type: Grant
    Filed: May 4, 2022
    Date of Patent: April 22, 2025
    Assignee: NUDGE BG, INC.
    Inventor: Lane Desborough
  • Patent number: 12237063
    Abstract: Some embodiments include burden-free insulin delivery systems and methods. In some embodiments, a method may include receiving previous insulin delivery data at a user device from an insulin pump; receiving estimated glucose data at the user device from a continuous glucose monitor; determining an insulin delivery amount based on the previous insulin delivery data and the estimated glucose data to bring the estimated glucose data closer to a target glucose value without using any user-specific behavioral data physically entered by a user through a user interface of the user device within a previous period of time, the previous period of time being less than six hours; and communicating the insulin delivery amount to the insulin pump.
    Type: Grant
    Filed: May 4, 2022
    Date of Patent: February 25, 2025
    Assignee: Nudge BG, Inc.
    Inventor: Lane Desborough
  • Patent number: 11942202
    Abstract: Some embodiments include burden-free insulin delivery systems and methods. Some embodiments include a method comprising: receiving previous insulin delivery data at a user device from an insulin pump; receiving estimated glucose data at the user device from a continuous glucose monitor; determining that the estimated glucose value is approaching or has passed a threshold; and in response to determining that the estimated glucose value is approaching or has surpassed the threshold, not providing an indication to the user through a user interface that the estimated glucose value is approaching or surpassed the threshold.
    Type: Grant
    Filed: August 16, 2021
    Date of Patent: March 26, 2024
    Assignee: Nudge BG, Inc.
    Inventor: Lane Desborough
  • Patent number: 11101030
    Abstract: Some embodiments include burden-free insulin delivery systems and methods. Some embodiments include a method comprising: receiving previous insulin delivery data at a user device from an insulin pump; receiving estimated glucose data at the user device from a continuous glucose monitor; determining that the estimated glucose value is approaching or has passed a threshold; and in response to determining that the estimated glucose value is approaching or has surpassed the threshold, not providing an indication to the user through a user interface that the estimated glucose value is approaching or surpassed the threshold.
    Type: Grant
    Filed: January 14, 2021
    Date of Patent: August 24, 2021
    Assignee: NUDGE BG, INC.
    Inventor: Lane Desborough